Discover
Visualize rapid, validated insights through real-world data.
Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company. Learn more →
Khaled El Emam, SVP & GM, Replica Analytics; Lucy Mosquera, Director Data Science, Replica Analytics
In this ISPOR webinar we gave an overview of synthetic data and its privacy preserving properties, advantages over traditional de-identification, and then reviewed results from a simulation of the validity of inference on synthetic oncology datasets.
There is no charge to view but registering on the site is required.